Join Dermstore Rewards to Unlock Exclusive Offers + Free Gift with ANY $200+ purchase.
FREE US Shipping $50+ Auto-Replenishment 15% off First App Order Dermstore Rewards Pay using HSA/FSA

Medik8 Exo-PDRN Prismatic+ 30ml

Current price: $96.00

Purchase Options
Deliver every
  • Save 15% on first order + 15% off future orders
  • Free delivery after your first order
  • Cancel or delay anytime

In stock | Usually dispatched within 24 hours

Free US Standard Delivery on orders over $50

Frequently Bought Together

Medik8 Exo-PDRN Prismatic+ 30ml

Medik8 Exo-PDRN Prismatic+ 30ml

$96.00

Medik8 Liquid Peptides Advanced MP 30ml

$95.00

ADD BOTH TO CART - $191.00

Product Description

Boost skin’s natural rejuvenation by +50%[1] with Exo-PDRN Prismatic+, a next-generation PDRN serum rooted in real skin biology. Inspired by advanced technologies once exclusive to clinical settings, this advanced serum is engineered to improve the overall quality of skin. Uncover a full-spectrum of results to restore visible vitality, refine tone and texture, boost luminosity and visibly reduce wrinkles.

Vegan Prismatic PDRN helps provide essential building blocks to support and aid in optimal skin recovery and calm visible redness. A highly concentrated Triple Exosome Complex, featuring up to 151 billion exosomes per bottle, facilitates skin resilience and reinforces the skin barrier.

Powerful when used daily and ideal alongside professional treatments.

Proven Results:

  • +50% boost in natural skin rejuvenation[1]
  • 7 days to improved skin barrier function, luminosity, skin volume, and tone [2]
  • 14 days to visibly improved wrinkles and firmness[2]
  • 100% agree this is the perfect post-procedure partner for their in-clinic polynucleotide treatment[3]
  • 98% agree this serum is an excellent post-procedure product to enhance the benefits of polynucleotide treatments[3]
  • 87% agree the overall quality of their skin has improved[4]

[1] Proven via ex vivo study measuring Ki67 protein marker for cell proliferation vs. untreated control after 24 hours

[2] Proven via independent clinical study on Exo-PDRN Prismatic+ on 60 volunteers over 1 week

[3] Proven via independent consumer study conducted over 4 weeks on 52 participants who had received injectable polynucleotide treatments within a week of the study

[4]Proven via independent consumer study on Exo-PDRN Prismatic+ on 104 volunteers over 4 weeks

[5]Proven via independent clinical study on Exo-PDRN Prismatic+ on 60 volunteers over 4 weeks